Overexpression of HOXA1 in chemotherapeutic-resistant SCLC cells significantly reduced cell proliferation and survival, as well as reduced the IC50 of chemotherapy needed for treatment. The gene discussed is HOXA1; the disease is small cell lung carcinoma.